Literature DB >> 6648816

The clinical course after definitive operation for medullary thyroid carcinoma.

C E Jackson, G B Talpos, A Kambouris, J B Yott, A H Tashjian, M A Block.   

Abstract

Thorough family studies that used the radioimmunoassay procedure for calcitonin (CT) during the past 12 years have provided data on 70 patients from 12 kindreds with hereditary medullary thyroid cancer (hereditary group) and 28 patients with sporadic or nonhereditary medullary thyroid cancer (sporadic group). Serum CT elevations after total thyroidectomy as evidence of residual tumor have been encountered in 21 of 25 patients in the hereditary group with palpable tumors preoperatively (84%) and in 13 of 24 in the sporadic group (54%). However, none of 26 patients with hereditary nonpalpable lesions found by family screening studies have been found to have postoperative CT elevations. Both cervical lymphadenectomy in patients with lymph node involvement at initial operation and reexploration in those with CT elevations after total thyroidectomy have been unsuccessful in the eradication of metastatic disease. These data emphasize the value of thorough family studies that use stimulated CT measurements in the detection of early and curable neoplasms. Involvement of the parathyroid glands or the adrenal medulla that occurred in the hereditary multiple endocrine neoplasia syndromes varied from family to family; it influenced the clinical course and required regular surveillance with calcium and catecholamine studies. Separation of hereditary from sporadic cases has practical value in the identification of family members at risk and also in the provision of prognostic data.

Entities:  

Mesh:

Year:  1983        PMID: 6648816

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

Review 1.  Multiple endocrine neoplasia.

Authors:  R A Decker; S A Wells
Journal:  Jpn J Surg       Date:  1989-11

2.  [Radicality principles in operations on malignant thyroid tumors].

Authors:  R A Wahl; P E Goretzki; K Joseph; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1985

3.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.

Authors:  F Raue; J Kotzerke; D Reinwein; S Schröder; H D Röher; H Deckart; R Höfer; M Ritter; F Seif; H Buhr
Journal:  Clin Investig       Date:  1993-01

4.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Authors:  H Dralle; I Damm; G F Scheumann; J Kotzerke; E Kupsch; H Geerlings; R Pichlmayr
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Treatment of medullary carcinoma of the thyroid by laryngo-pharyngo-oesophagectomy--a case report.

Authors:  S Pender; D M Little; P Burke; P Broe
Journal:  Ir J Med Sci       Date:  1992-07       Impact factor: 1.568

Review 6.  Evidence-based approach to the management of sporadic medullary thyroid carcinoma.

Authors:  Jeffrey F Moley; Elizabeth A Fialkowski
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

7.  Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology.

Authors:  Karishma Jassal; Nandhini Ravintharan; Swetha Prabhakaran; Simon Grodski; Jonathan W Serpell; James C Lee
Journal:  ANZ J Surg       Date:  2022-04-12       Impact factor: 2.025

8.  Twenty years of experience with the preoperative diagnosis of medullary cancer in a moderately iodine-deficient region.

Authors:  Tamas Solymosi; Gyula Lukacs Toth; Dezso Nagy; Istvan Gal
Journal:  Int J Endocrinol       Date:  2013-03-06       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.